Search Saint Luke's

Saint Luke’s Health System Antimicrobial and Diagnostic Advisement Program (ADAP) aims to promote the judicious use of antimicrobials, suppress antimicrobial resistance, decrease the negative effects of unnecessary antimicrobial use, and improve outcomes for the patients we serve.

Pancreatic Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Anderson County Hospital is pleased to announce the continuation of a nursing scholarship program

Cardiopulmonary Bypass | Kidney Disease
ARTEMIS: RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

Mitral Regurgitation
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population

As President and CEO of an aviation company headquartered in New York City, Ron Ricciardi is constantly on the go. The Kansas City resident splits his time between his home in the Midwest and his office on the East Coast, commuting one direction or the other every week by plane.

Learn more about Saint Luke's Health System's awards and recognition.

Cardiometabolic

A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death in Participants with Increased Risk of Developing Heart Failure

Now starting his freshman year at Missouri Western University on a football scholarship, Jaylen Parks is grateful to Rockhill Orthopaedic Specialists for helping him get back on the field.

As a football quarterback, Montell Cozart was accustomed to calling the signals. But in the summer of 2023, he learned a lesson in listening to the signs his body was sending him.